For example, clear cell renal cell carcinoma (ccRCC) patients with von Hippel-Lindau (VHL) gene mutation showed a better survival trend compared with ccRCC patients with titin (TTN) gene mutation. This evidence concerns the gene TTN and nonpapillary renal cell carcinoma.